4-oxo-4-((5-phenyl-1,3,4-thiadiazol-2-yl)amino)butanoic acid
|
- $68.1 - $501.38
- Product name: 4-oxo-4-((5-phenyl-1,3,4-thiadiazol-2-yl)amino)butanoic acid
- CAS: 339240-01-6
- MF: C12H11N3O3S
- MW: 277.3
- EINECS:
- MDL Number:MFCD00735361
- Synonyms:4-oxo-4-((5-phenyl-1,3,4-thiadiazol-2-yl)amino)butanoic acid;Butanoic acid, 4-oxo-4-[(5-phenyl-1,3,4-thiadiazol-2-yl)amino]-
2 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 50mg
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM1024307
- Product description4-OXO-4-((5-PHENYL-1,3,4-THIADIAZOL-2-YL)AMINO)BUTANOIC ACID 95.00%
- Packaging5MG
- Price$501.38
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberCDS006422
- Product description4-oxo-4-((5-phenyl-1,3,4-thiadiazol-2-yl)amino)butanoic acid AldrichCPR
- Packaging50mg
- Price$68.1
- Updated2023-06-20
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | CHM1024307 | 4-OXO-4-((5-PHENYL-1,3,4-THIADIAZOL-2-YL)AMINO)BUTANOIC ACID 95.00% | 5MG | $501.38 | 2021-12-16 | Buy |
| Sigma-Aldrich | CDS006422 | 4-oxo-4-((5-phenyl-1,3,4-thiadiazol-2-yl)amino)butanoic acid AldrichCPR | 50mg | $68.1 | 2023-06-20 | Buy |
Properties
Density :1.449±0.06 g/cm3(Predicted)
pka :4.25±0.10(Predicted)
form :solid
InChI :1S/C12H11N3O3S/c16-9(6-7-10(17)18)13-12-15-14-11(19-12)8-4-2-1-3-5-8/h1-5H,6-7H2,(H,17,18)(H,13,15,16)
InChIKey :JBHZCNZCQPNDNW-UHFFFAOYSA-N
SMILES :OC(=O)CCC(=O)Nc1nnc(s1)-c2ccccc2
pka :4.25±0.10(Predicted)
form :solid
InChI :1S/C12H11N3O3S/c16-9(6-7-10(17)18)13-12-15-14-11(19-12)8-4-2-1-3-5-8/h1-5H,6-7H2,(H,17,18)(H,13,15,16)
InChIKey :JBHZCNZCQPNDNW-UHFFFAOYSA-N
SMILES :OC(=O)CCC(=O)Nc1nnc(s1)-c2ccccc2
Safety Information
| Symbol(GHS): |
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal word: | Warning | ||||||||||||||
| Hazard statements: |
|
||||||||||||||
| Precautionary statements: |
|